Stockscreener 앱 받기
19.14
0.10%
-0.02
전일 마감가:
$19.16
열려 있는:
$19.31
하루 거래량:
149.89K
Relative Volume:
0.65
시가총액:
$883.75M
수익:
$705.70M
순이익/손실:
$-61.80M
주가수익비율:
-16.08
EPS:
-1.19
순현금흐름:
$14.60M
1주 성능:
+7.11%
1개월 성능:
-14.32%
6개월 성능:
-4.11%
1년 성능:
-10.89%
1일 변동 폭
$19.11
$19.48
1주일 범위
$17.84
$19.56
52주 변동 폭
$17.39
$25.36
Avanos Medical Inc Stock (AVNS) Company Profile
명칭
Avanos Medical Inc
전화
844-428-2667
주소
5405 WINDWARD PARKWAY, ALPHARETTA, GA
AVNS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AVNS
Avanos Medical Inc
|
19.14 | 883.75M | 705.70M | -61.80M | 14.60M | -1.19 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Avanos Medical Inc Stock (AVNS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-07-25 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-22 | 개시 | CL King | Buy |
| 2021-08-04 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2020-04-13 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2019-11-07 | 다운그레이드 | Stifel | Buy → Hold |
| 2019-11-06 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2018-10-16 | 개시 | Barclays | Equal Weight |
| 2018-08-21 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
모두보기
Avanos Medical Inc 주식(AVNS)의 최신 뉴스
AVNS (Avanos Medical) Debt-to-EBITDA : 2.07 (As of Sep. 2024) - GuruFocus.com
AVNS (Avanos Medical) Shares Outstanding (EOP) : 46.0 Mil (As of Sep. 2024) - GuruFocus.com
Q3 EPS Estimates for Avanos Medical Decreased by Analyst - MarketBeat
FY2024 EPS Estimates for Avanos Medical Decreased by Analyst - MarketBeat
Empowered Funds LLC Cuts Position in Avanos Medical, Inc. (NYSE:AVNS) - MarketBeat
Synaptrix announces tranche update - Marketscreener.com
Avanos Medical (STU:8HH) EPS without NRI : €1.13 (TTM As of Sep. 2024) - GuruFocus.com
How to Take Advantage of moves in (AVNS) - Stock Traders Daily
Synaptrix announced that it expects to receive funding from Hatteras Venture Advisors VI, LLC, Rex Health Ventures, Avanos Medical, Inc., Portal Innovations, LLC - Marketscreener.com
AVNS (Avanos Medical) Inventory-to-Revenue : 0.96 (As of Sep. 2024) - GuruFocus.com
Janney Montgomery Scott LLC Has $863,000 Stock Holdings in Avanos Medical, Inc. (NYSE:AVNS) - Defense World
Cornercap Investment Counsel Inc. Sells 28,302 Shares of Avanos Medical, Inc. (NYSE:AVNS) - MarketBeat
T. Rowe Price Investment Management, Inc. Expands Stake in Avanos Medical Inc - GuruFocus.com
Avanos Medical CEO to Present at Stifel Healthcare Conference: Key Investor Updates | AVNS Stock News - StockTitan
Avanos Medical, Inc. to Present at the Stifel 2024 Healthcare Conference - WV News
ON-Q* Elastomeric Infusion Pump and ambIT* Disposable Electronic Infusion Pump to Receive Separate Payment Under NOPAIN Act Starting January 1, 2025 - PR Newswire
Avanos Medical Secures Medicare Coverage for Non-Opioid Pain Pumps Under NOPAIN Act | AVNS Stock News - StockTitan
Avanos Medical CEO to Present at UBS Healthcare Conference | Key Industry Insights | AVNS Stock News - StockTitan
We Think Avanos Medical's (NYSE:AVNS) Healthy Earnings Might Be Conservative - Yahoo Finance
Avanos Medical announces $25 million stock buyback program By Investing.com - Investing.com Australia
Avanos Medical's SWOT analysis: healthcare firm's stock faces transformation hurdles - Investing.com India
Avanos Medical, Inc. Launches New CORGRIP SR - Marketscreener.com
Avanos Medical Launches New CORGRIP® SR - PR Newswire
Avanos Medical announces $25 million stock buyback program - Investing.com India
Avanos Medical (NYSE:AVNS) Lowered to Buy Rating by StockNews.com - Defense World
StockNews.com Downgrades Avanos Medical (NYSE:AVNS) to Buy - MarketBeat
Are Investors Undervaluing Avanos Medical (AVNS) Right Now? - MSN
Avanos Medical Third Quarter 2024 Earnings: EPS: US$0.13 (vs US$0.19 loss in 3Q 2023) - Yahoo Finance
Avanos Medical, Inc. (NYSE:AVNS) Q3 2024 Earnings Call Transcript - Insider Monkey
Avanos Q3 Earnings Meet Estimates, Sales Miss, Gross Margin Contracts - Yahoo Canada Finance
Earnings call: Avanos Medical Q3 results and strategic updates By Investing.com - Investing.com South Africa
Earnings call: Avanos Medical Q3 results and strategic updates - Investing.com India
Avanos Medical Inc Reports Q3 2024 Earnings: EPS at $0.12, Reven - GuruFocus.com
Avanos Medical Inc (AVNS) Q3 2024 Earnings Call Highlights: Strong Financial Performance Amid ... - Yahoo Finance
Avanos Medical Inc (AVNS) Q3 2024 Earnings Call Highlights: Stro - GuruFocus.com
Avanos Medical Reports Q3 Results and CEO Retirement - TipRanks
Stifel cuts Avanos Medical target to $20 from $24, keeps hold rating - Investing.com Canada
Where are the Opportunities in (AVNS) - Stock Traders Daily
Avanos Medical: Q3 Earnings Snapshot - Houston Chronicle
Avanos Medical (NYSE:AVNS) Shares Gap DownTime to Sell? - MarketBeat
Avanos Medical (AVNS) Q3 Earnings Meet Estimates - MSN
Avanos Names CFO Greiner Interim CEO as Woody Retires, 3Q Sales Slip - MarketWatch
Avanos Medical reports Q3 financials, CEO retires - Investing.com
Avanos Medical (NYSE:AVNS) Issues FY 2024 Earnings Guidance - MarketBeat
Avanos Medical Announces CEO Retirement and Interim Appointment - TipRanks
Avanos Medical reports Q3 financials, CEO retires By Investing.com - Investing.com UK
Avanos Medical earnings beat by $0.01, revenue fell short of estimates - Investing.com UK
Avanos Medical, Inc. Announces Third Quarter 2024 Results, retirement of CEO - PR Newswire
Tributary Capital Management LLC Has $15.54 Million Stock Holdings in Avanos Medical, Inc. (NYSE:AVNS) - MarketBeat
Avanos Medical (NYSE:AVNS) Upgraded by StockNews.com to Strong-Buy - MarketBeat
Avanos Medical, Inc.'s (NYSE:AVNS) Price Is Right But Growth Is Lacking - Simply Wall St
Avanos Medical Inc (AVNS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.65%
자본화:
|
볼륨(24시간):